110 related articles for article (PubMed ID: 16095109)
1. Antifolate/antiproliferative therapy in rheumatoid arthritis.
Cutolo M
Clin Exp Rheumatol; 2005; 23(4):435-7. PubMed ID: 16095109
[No Abstract] [Full Text] [Related]
2. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
Khan S
Med Hypotheses; 2008 Nov; 71(5):818. PubMed ID: 18650027
[No Abstract] [Full Text] [Related]
3. Methotrexate therapy for rheumatoid arthritis.
Vega IL
Am Fam Physician; 2015 Jan; 91(1):26-7. PubMed ID: 25591196
[No Abstract] [Full Text] [Related]
4. Novel phosphoinositide 3-kinase δ,γ inhibitor: potent anti-inflammatory effects and joint protection in models of rheumatoid arthritis.
Boyle DL; Kim HR; Topolewski K; Bartok B; Firestein GS
J Pharmacol Exp Ther; 2014 Feb; 348(2):271-80. PubMed ID: 24244039
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
Gerlag DM; Tak PP
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment.
Smith MD; Weedon H; Papangelis V; Walker J; Roberts-Thomson PJ; Ahern MJ
Rheumatology (Oxford); 2010 May; 49(5):862-75. PubMed ID: 20147446
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition as a novel therapy in treating rheumatoid arthritis.
Brun J
Med Hypotheses; 2008; 71(1):65-72. PubMed ID: 18424014
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
Morgan SL; Baggott JE; Lee JY; Alarcón GS
J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
[TBL] [Abstract][Full Text] [Related]
11. MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction?
Müller-Ladner U; Gay S
Ann Rheum Dis; 2002 Nov; 61(11):957-9. PubMed ID: 12379515
[No Abstract] [Full Text] [Related]
12. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinases as targets in rheumatoid arthritis.
Tristano AG
Int Immunopharmacol; 2009 Jan; 9(1):1-9. PubMed ID: 18848912
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of methotrexate versus CH-1504 in the treatment of rheumatoid arthritis.
Castaneda O; Nair MG
J Rheumatol; 2006 May; 33(5):862-4. PubMed ID: 16652417
[TBL] [Abstract][Full Text] [Related]
15. Metabolism-blocked antifolates as potential anti-rheumatoid arthritis agents: 4-amino-4-deoxy-5,8,10-trideazapteroyl-d,l-4'-methyleneglutamic acid (CH-1504) and its analogs.
McGuire JJ; Haile WH
Biochem Pharmacol; 2009 Apr; 77(7):1161-72. PubMed ID: 19174154
[TBL] [Abstract][Full Text] [Related]
16. Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.
Klaasen R; Wijbrandts CA; van Kuijk AW; Pots D; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Jul; 71(7):1260-1. PubMed ID: 22345123
[No Abstract] [Full Text] [Related]
17. Potential food-drug interactions in patients with rheumatoid arthritis.
Masuko K; Tohma S; Matsui T
Int J Rheum Dis; 2013 Apr; 16(2):122-8. PubMed ID: 23773634
[TBL] [Abstract][Full Text] [Related]
18. Does partial control of inflammation prevent long-term joint damage? Clinical rationale for combination therapy with multiple disease-modifying antirheumatic drugs.
Pincus T; Breedveld FC; Emery P
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S2-7. PubMed ID: 10589350
[No Abstract] [Full Text] [Related]
19. Mechanism for spread of rheumatoid arthritis.
Nurse Educ; 2010; 35(2):55. PubMed ID: 20173587
[No Abstract] [Full Text] [Related]
20. [Methotrexate treatment in non-cancerous disorders].
Cogan E
Rev Med Brux; 1995; 16(4):300-3. PubMed ID: 7481247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
